Skip to content

Clinical study of traditional Chinese medicine Yushen reciption in the intervention of early chronic allograft nephropathy

Clinical study of traditional Chinese medicine Yushen reciption in the intervention of early chronic allograft nephropathy.

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015689
Enrollment
Unknown
Registered
2018-04-15
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic allograft nephropathy

Interventions

Treatment group:CNI (CsA/FK506 + MMF + Pred) plus Yushen Recipe
Control:CNI (CsA/FK506 + MMF + Pred)

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) conform to the diagnostic criteria of chronic allograft nephropathy and the dialectical standard of traditional Chinese medicine; 2) aged 18~70 years; 3) after 12 months of transplantation; 4) serum creatinine (Scr) < 250 mol/L; 5) no hemodialysis or peritoneal dialysis treatment; 6) no severe acute and chronic digestive tract disease; 7) willing to participate in the trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) renal function damage caused by acute rejection, virus infection, acute CsA/FK506 renal toxicity, obstruction / reflux, renal vascular stenosis and other pathological changes in clinical and / or renal allograft pathology; 2) combined with serious diseases such as heart, liver and blood system; 3) women in pregnancy or lactation; 4) people who were allergic to this medicine; 5) psychosis.

Design outcomes

Primary

MeasureTime frame
creatinine;Cystatin;eGFR;CD4 T;CD8 T;Urinary albumin / creatinine ratio;Interleaf arterial resistance index;Arcuate artery resistance index;Resistance index of segmental artery;

Countries

China

Contacts

Public ContactQin Yan

Shanghai General Hospital

yanqin12@hotmail.com+86 18602194937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026